✦ LIBER ✦

Entacapone in the treatment of Parkinson's disease

✍ Scribed by Anette Schrag

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term retention rate of entacapone i

✍ T. Keränen; M. Tuhkasaari; H. Kuusisto 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Use of the new levodopa agent Stalevo (l

✍ A. N. Boiko; T. T. Batysheva; N. G. Minaeva; L. A. Babina; T. V. Vdovichenko; E. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 200 KB

1-30-16 Cardiovascular safety of entacap

✍ J. Lyytinen; S. Kaakkola; A. Gordin; H. Teräväinen 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Levodopa/DDCI and entacapone is the pref

✍ P. Damier; F. Viallet; M. Ziegler; I. Bourdeix; K. Rerat 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

A single-blind cross over study investig

✍ R. Iansek; M. Danoudis 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Levodopa/carbidopa/entacapone in Parkins

✍ Seeberger, Lauren C; Hauser, Robert A 📂 Article 📅 2009 🏛 Expert Reviews 🌐 English ⚖ 894 KB